What we know about epidemiology of heart failure in Slovakia and globally

Vnitrni Lekarstvi
|November 17, 2018
PubMed

Insights

Heart failure prevalence in Slovakia is 2.3%, with higher rates in older adults. Hospitalizations for heart failure are increasing, indicating a growing public health concern requiring resource adaptation.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Heart failure (HF) is a major cause of mortality, morbidity, and hospitalization globally.
  • The increasing prevalence of HF presents significant challenges to healthcare and social welfare systems.
  • Understanding HF epidemiology is vital for effective healthcare planning, prevention strategies, and research allocation.

Purpose of the Study:

  • To describe the epidemiological characteristics of heart failure in Slovakia.
  • To analyze trends in heart failure hospitalizations and associated mortality.
  • To project future trends in heart failure prevalence and healthcare needs.

Main Methods:

  • Cross-sectional surveys of outpatient care and hospitalization records.
  • Analysis of data from the National Health Information Center and Dôvera health insurer.
  • Calculation of crude and age-specific prevalence, average age, and functional class distribution.

Main Results:

  • Crude HF prevalence in Slovakia is 2.3%, with age-specific prevalence increasing significantly in older age groups.
  • Ischemic heart disease is the most common cause (50-60%), and 26-43% of patients have reduced left ventricular ejection fraction.
  • Hospitalizations for HF have dramatically increased from 9,060 in 2005 to 22,112 in 2017, with a hospitalization mortality rate of 6.2%.

Conclusions:

  • The prevalence of chronic heart failure is projected to rise due to an aging population and improved survival rates.
  • Healthcare resources, both material and human, must be adapted to meet the growing demand for HF care.
  • Further research is needed to obtain exact incidence data for heart failure in Slovakia.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319